MBD2-MBD3 Complex Regulates TGF-β Signaling Pathway (P17922)

Target Name: MBD2-MBD3 complex

NCBI ID: P17922

MBD2-MBD3 complex

Other Name(s): None

MBD2-MBD3 Complex Regulates TGF-β Signaling Pathway

The MBD2-MBD3 complex is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and bone. It is a transmembrane protein that is involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the development, maintenance, and regulation of tissues, and is a key factor in the development of many diseases, including cancer.

The MBD2-MBD3 complex is composed of two subunits, MBD2 and MBD3. MBD2 is a 24kDa protein that is expressed in various tissues, including the brain, and is involved in the regulation of TGF-β signaling pathway. MBD3 is a 19kDa protein that is also expressed in various tissues, including the brain, and is involved in the regulation of TGF-β signaling pathway.

The MBD2-MBD3 complex plays a key role in the regulation of TGF-β signaling pathway. TGF-β is a cytokine that is involved in the development and maintenance of tissues, and is a key factor in the development of many diseases, including cancer . The MBD2-MBD3 complex is involved in the regulation of TGF-β signaling pathway by controlling the activity of the transcription factor Smad.

Smad is a protein that is involved in the regulation of gene expression, and is a key factor in the TGF-β pathway. The MBD2-MBD3 complex is involved in the regulation of Smad activity by controlling the activity of the protein Myr1. Myr1 is a 22kDa protein that is involved in the regulation of TGF-β signaling pathway, and is a key factor in the MBD2-MBD3 complex.

The MBD2-MBD3 complex is also involved in the regulation of cell signaling pathways that are involved in the development and maintenance of tissues. For example, the MBD2-MBD3 complex is involved in the regulation of the development and maintenance of the blood vessels, and is involved in the regulation of the angiogenesis process. The MBD2-MBD3 complex is also involved in the regulation of the development and maintenance of the bone, and is involved in the regulation of the osteogenic process.

In conclusion, the MBD2-MBD3 complex is a protein that is involved in the regulation of cell signaling pathways that are involved in the development and maintenance of tissues. It is composed of two subunits, MBD2 and MBD3, and is expressed in various tissues, including the brain, heart, liver, and bone. The MBD2-MBD3 complex plays a key role in the regulation of TGF-β signaling pathway by controlling the activity of the transcription factor Smad, and is also involved in the regulation of cell signaling pathways that are involved in the development and maintenance of tissues. Therefore, it may be a drug target or biomarker for the development of many diseases, including cancer.

Protein Name: MBD2-MBD3 Complex

The "MBD2-MBD3 complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MBD2-MBD3 complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets